do you build a tolerance to glp 1 GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Nobody tells you this when

Compounded semaglutide and tirzepatide are not the same medications as branded GLP-1 drugs and are not branded or FDA-approved products

This is not another introductory article

The number of dead cells was determined by staining with trypan blue, and cells were counted using a Neubauer hemocytometer

The major cardiovascular safety trials The SUSTAIN-6 trial enrolled 3,297 patients with type 2 diabetes and high cardiovascular risk, following them for two years on semaglutide 0.5 mg or 1.0 mg weekly versus placebo

Implementation typically involves collaboration with PCPs or endocrinologists to initiate and titrate treatment, monitor metabolic parameters, and manage adverse effects